Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease

Annals of Surgery

Volumn 226, Issue 5, 1997, Pages 632-641

  Lowy, Andrew M ^a   Lee, Jeffrey E ^a   Pisters, Peter W T ^a   Davidson, B Scott ^a   Fenoglio, Claudia J ^a   Stanford, Pam ^a   Jinnah, Rashida ^a   Evans, Douglas B ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BILE DUCT CARCINOMA; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DUODENUM CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PANCREAS CARCINOMA; PANCREAS FISTULA; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROPERITONEAL CANCER; SUBCUTANEOUS DRUG ADMINISTRATION; SURGICAL TECHNIQUE; VATER PAPILLA CARCINOMA;

ADULT; AGED; FEMALE; HORMONES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OCTREOTIDE; PANCREATIC FISTULA; PANCREATICODUODENECTOMY; PROSPECTIVE STUDIES;

EID: 0031460248     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199711000-00008     Document Type: Article

References (40)

1. Cullen JJ, Sarr MG, Ilstrup DM. Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management. Am J Sura 1994;168:295-298.
2. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinorna. Am J Surg 1993;165:68-73.
3. Marcus ST, Cohen H, Ranson JHC. Optimal management of the pancreatic remnant after pancreaticoduodenectomy. Ann Surg 1995;221:635-638.
4. Fernandez-del Castillo C, Rattner DW, Warshaw AL. Standards for pancreatic resection in the 1990s. Arch Surg 1995;130:295-300.
5. Yeo CJ, Cameron JL, Maher MM, et al. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 1995;222:580-592.
6. Staley CA, Lee JE, Cleary KR, et al. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 1996;171:118125.
7. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995;221:721-733.
8. Sing RF, Reilly PM, Schwab CW. The single-layered, parachuted intussuscepted pancreaticojejunostomy. Am Surg 1995;61:322-323.
9. Hiraoka T, Kanemitsu K, Tsuji T, et al. A method for sate pancreaticojejunostomy. Am J Surg 1993;165:270-272.
10. Matsumoto Y, Fujii H, Miura K, et al. Successful pancreaticojejunal anastomosis for pancreaticoduodenectomy. Surg Gynecol Obstet 1992;175:555-562.
11. Hamanaka Y, Suzuki T. Total pancreatic duct drainage for leakproof pancreaticojejunostomy. Surgery 1994;115:22-26.
12. Keck H, Steffen R, Neuhaus P. Protection of pancreatic and biliary anastomosis after partial duodenopancreatectomy by external drainage. Surg Gynecol Obstet 1992;174:329-331.
13. Cameron JL. Atlas of Surgery, Vol. 1. Philadelphia: Decker/MosbyYear Book; 1990:402-403.
14. Tashior S, Murata E, Hiraoka T, et al. New technique for pancreaticojejunostomy using a biological adhesive. Br J Surg 1987;74:392-394.
15. Reissman P, Perry Y, Cuenca A, et al. Pancreaticojejunostomy versus controlled pancreaticocutaneous fistula in pancreaticoduodenectomy for periampullary carcinoma. Am J Surg 1995;169:585-588.
16. Di Carlo V, Chiesa R, Pontiroli AH, et al. Pancreaticoduodenectomy with occlusion of the residual stump by Neoprene injection. World J Surg 1989;13:105-111.
17. Miyagawa S, Makuuchi M, Kawasaki S, Ogiwara M. Second-stage pancreaticojejunostomy following pancreaticoduodenectomy in high-risk patients. Am J Surg 1994;168:66-68.
18. Williams ST, Woltering EA, O'Dorisio TM, Fletcher WS. Effect of octreotide acetate on pancreatic exocrine function. Am J Surg 1989;157:459-462.
19. Pederzoli P, Bassi C, Falconi M, et al. Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostalin, glucagon or calcitonin. Surg Gynecol Obstet 1986;163:428-432.
20. Prinz RA, Pickleman J, Hoffman JP. Treatment of pancreatic cutaneous fistulas with a somatostalin analog. Am J Surg 1988;155:36-42.
21. Büchler M, Friess H, Kelmpa I, et al. Role of octreotide in the prevention of postoperative complication following pancreatic resection. Am J Surg 1992;163:125-131.
22. Montorsi M, Zago M, Mosca F, et al. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized trial. Surgery 1995;117:26-31.
23. Pederzoli P, Bassi C, Falconi M, Camboni MG. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Br J Surg 1994;81:265-269.
24. Fuhrman GM, Charnsangavej C, Abbruzzese JL, et al. Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg 1994;167:104-113.
25. Sptiz FR, Abbruzzese JL, Lee JE, et al. Preoperative and postoperative chemoradiatton strategies in patients with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Orthop 1997;15:928-937.
26. Evans DB, Lee JE, Leach SD, et al. Vascular resection and intraoperative radiation therapy during pancreaticoduodenectomy: rationale and technique. Adv Surg 1996;29:235-262.
27. Evans DB, Lee JE, Pisters PWT. Pancreaticoduodenectomy (Whipple operation) and total pancreatectomy for cancer. In: Nyhus LM, Baker RJ, Fischer JF, eds. Mastery of Surgery, 3d ed. Boston: Little, Brown and Co. 1997, 1233-1249.
28. Evans DB, Termuhlen PM, Byrd DR, et al. Intraoperative radiation therapy following pancreaticoduodenectomy. Ann Surg 1993; 218:54-60.
29. Staley CA, Cleary KA, Abbruzzese JA, et al. Need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas 1996;12:373-380.
30. Evans DB. Pancreaticoduodenectomy. In: Roh M, Ames FC, eds. Atlas of Advanced Surgical Oncology. London: Mosby-Year Book; 1994;4.2-4.45.
31. Tyler DS, Evans DB. Reoperative pancreaticoduodenectomy. Ann Surg 1994;2:211-221.
32. Harris AG: Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. Gut 1994;35(suppl 3):S1-S4.
33. Lamberts SWJ, van der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N Engl J Med 1996;334:246-254.
34. Hamanaka Y, Nishihara K, Hamasaki T, et al. Pancreatic juice after pancreaticoduodenectomy in relation to pancreatic consistency, duct size, and leakage. Surgery 1996;119:281-287.
35. Evans DB, Abbruzzese JL, Cleary KR, et at. Rapid-fractionation preoperative chemoradiation for malignant periampullary neoplasms. J R Coll Surg Edinb 1995;40:319-323.
36. Ishikawa O, Ohigashi H, Imaoka S, et al. Concomitant benefit of preoperative irradiation in preventing pancreas fistula formation after pancreaticoduodenectomy. Arch Surg 1991;126:885-889.
37. Robinson EK, Lowy AM, Fenoglio CJ, et al. Reoperative pancreaticoduodenectomy for periampullary carcinoma. Am J Surg 1996;172:432-438.
38. Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. N Engl J Med 1996;334:1209-1215.
39. Fuhrman GM, Leach SD, Staley CA, et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Ann Surg 1996;223:154-162.
40. Brodsky JT, Turnbull ADM. Arterial hemorrhage after pancreaticoduodenectomy: the sentinel bleed. Arch Surg 1991;126:1037-1040.